scholarly article | Q13442814 |
P2093 | author name string | Chao Gao | |
Liang Liu | |||
Ping Yao | |||
Zhiyong Gong | |||
P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages | Q24310677 | ||
Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins | Q26865113 | ||
Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). | Q30452333 | ||
Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation | Q33694286 | ||
Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells | Q34217939 | ||
Autophagy and non-alcoholic fatty liver disease. | Q34247340 | ||
Accumulation of oxidized LDL in the tendon tissues of C57BL/6 or apolipoprotein E knock-out mice that consume a high fat diet: potential impact on tendon health | Q34689600 | ||
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study | Q34726987 | ||
Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. | Q35044164 | ||
Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice. | Q35115065 | ||
Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis | Q35683158 | ||
Specific immunization strategies against oxidized low-density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice | Q36030999 | ||
Potential role of the ubiquitin-proteasome system in atherosclerosis: aspects of a protein quality disease | Q37171271 | ||
Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review | Q37232413 | ||
Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome | Q37693238 | ||
Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment | Q37873715 | ||
Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents | Q38024145 | ||
Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue | Q38223370 | ||
Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer | Q38265625 | ||
Quercetin protects macrophages from oxidized low-density lipoprotein-induced apoptosis by inhibiting the endoplasmic reticulum stress-C/EBP homologous protein pathway | Q38323245 | ||
A concise review of non-alcoholic fatty liver disease | Q38330913 | ||
Multitarget effects of quercetin in leukemia. | Q38949868 | ||
Quercetin attenuates renal ischemia/reperfusion injury via an activation of AMP-activated protein kinase-regulated autophagy pathway. | Q38969160 | ||
Quercetin 3-rhamnoside exerts antiinfluenza A virus activity in mice | Q39512740 | ||
Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling | Q39536860 | ||
The flavonoids. A class of semi-essential food components: their role in human nutrition | Q40621696 | ||
Quercetin prevents ethanol-induced iron overload by regulating hepcidin through the BMP6/SMAD4 signaling pathway | Q42218715 | ||
Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease | Q42702473 | ||
Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells | Q42713260 | ||
Non-alcoholic fatty liver disease: a practical approach to treatment | Q42913256 | ||
The autophagy-lysosome pathway: a novel mechanism involved in the processing of oxidized LDL in human vascular endothelial cells | Q43133168 | ||
Flavonol and flavone intakes in US health professionals | Q44191331 | ||
Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis | Q45031991 | ||
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis | Q46455735 | ||
Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils | Q46609574 | ||
Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH). | Q46825081 | ||
Proteasome inhibition by quercetin triggers macroautophagy and blocks mTOR activity. | Q53213320 | ||
Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice. | Q53618329 | ||
Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages | Q54290578 | ||
A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein. | Q54340432 | ||
Dietary Intakes of Flavonols and Flavones and Coronary Heart Disease in US Women | Q61565513 | ||
Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C | Q79868106 | ||
Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study | Q81441440 | ||
Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes | Q83742370 | ||
Proatherogenic macrophage activities are targeted by the flavonoid quercetin | Q84744670 | ||
Western diet in ApoE-LDLR double-deficient mouse model of atherosclerosis leads to hepatic steatosis, fibrosis, and tumorigenesis | Q85270190 | ||
Quercetin decreases liver damage in mice with non-alcoholic steatohepatitis | Q85918954 | ||
Mirtoselect, an anthocyanin-rich bilberry extract, attenuates non-alcoholic steatohepatitis and associated fibrosis in ApoE(∗)3Leiden mice | Q86305380 | ||
Comparative effect of pioglitazone, quercetin and hydroxy citric acid on the status of lipid peroxidation and antioxidants in experimental non-alcoholic steatohepatitis | Q95564527 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lipoprotein | Q28350 |
autophagy | Q288322 | ||
P304 | page(s) | 607531 | |
P577 | publication date | 2015-12-01 | |
P1433 | published in | BioMed Research International | Q17509958 |
P1476 | title | Quercetin Alleviates High-Fat Diet-Induced Oxidized Low-Density Lipoprotein Accumulation in the Liver: Implication for Autophagy Regulation | |
P478 | volume | 2015 |
Q92265905 | ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy |
Q99571242 | Fermented mulberry (Morus alba) leaves suppress high fat diet-induced hepatic steatosis through amelioration of the inflammatory response and autophagy pathway |
Q90376388 | Ginkgolide C reduced oleic acid-induced lipid accumulation in HepG2 cells |
Q40979699 | Linarin Enriched Extract Attenuates Liver Injury and Inflammation Induced by High-Fat High-Cholesterol Diet in Rats |
Q46373476 | Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative. |
Q90291199 | Quercetin has a protective effect on atherosclerosis via enhancement of autophagy in ApoE-/- mice |
Q28817618 | Shugan Xiaozhi Decoction Attenuates Nonalcoholic Steatohepatitis by Enhancing PPARα and L-FABP Expressions in High-Fat-Fed Rats |
Q64085329 | Tangshen Formula Alleviates Hepatic Steatosis by Inducing Autophagy Through the AMPK/SIRT1 Pathway |
Search more.